References
[1] Parish T, Stoker NG. The common aromatic amino acid biosynthesis pathway is essential in Mycobacterium tuberculosis. Microbiology 2002;148:3069–77.
[2] Oliveira JS, Pinto CA, Basso LA, Santos DS. Cloning and overexpression in soluble form of functional shikimate kinase and 5-enolpyruvylshikimate 3-phosphate synthase enzymes from Mycobacterium tuberculosis. Protein Expr Purif 2001;22:430-435
[3] Simithy J, Gill G, Wang Y, Goodwin DC, Calderón AI. Development of an ESI-LC-MS-based assay for kinetic evaluation of mycobacterium tuberculosis shikimate kinase activity and inhibition. Anal Chem 2015;87:2129–36.
[4] Tachibana H. Green tea polyphenol sensing. Proc Jpn Acad Ser B Phys Biol Sci 2011;87:66–80.
[5] Velayutham P, Babu A, Liu D, Gilbert ER. Recent advances in understanding the anti-diabetic actions of dietary flavonoids n.d. J Nutr Biochem 2013;24(11):1777-1789
[6] Gibbons S. Phytochemicals for bacterial resistance - Strengths, weaknesses and opportunities. Planta Med., 2008;74(6):594-602 https://doi.org/10.1055/s-2008-1074518.
[7] Pandey S, Chatterjee A, Jaiswal S, Kumar S, Ramachandran R, Srivastava KK. Protein kinase C-Δ inhibitor, Rottlerin inhibits growth and survival of mycobacteria exclusively through Shikimate kinase. Biochem Biophys Res Commun 2016;478:721–6.
[8] Chatterjee A, Pandey S, Singh PK, Pathak NP, Rai N, Ramachandran R, et al. Biochemical and functional characterizations of tyrosine phosphatases from pathogenic and nonpathogenic mycobacteria: indication of phenyl cyclopropyl methyl-/phenyl butenyl azoles as tyrosine phosphatase inhibitors. Appl Microbiol Biotechnol 2015;99:7539–48.
[9] Mehta S, Mehta SS, Thokchom SK, Patyal P. A critical insight into shikimate kinase pathway. Innovare Academic Sciences 2015;7:25–7.
[10] Singh AK, Yadav P, Karaulia P, Singh VK, Gupta P, Puttrevu SK, et al. Biological evaluation of novel curcumin-pyrazole-mannich derivative active against drug-resistant Mycobacterium tuberculosis. Future Microbiol 2017.